Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia
- Equal contributors
1 Department of Health Officer, Institute of Public Health, College of Medicine and Health Sciences, The University of Gondar, Gondar, Ethiopia
2 Department of Environmental and Occupational Health and Safety, Institute of Public Health, College of Medicine and Health Sciences, The University of Gondar, P.O.Box 196, Gondar, Ethiopia
3 Department of Epidemiology and Biostatistics, School of Public Health, College of Medicine and Health Sciences, The University of Bahirdar, P.O.Box 79, Bahirdar, Ethiopia
BMC Infectious Diseases 2013, 13:292 doi:10.1186/1471-2334-13-292Published: 28 June 2013
Tuberculosis (TB) is the leading killer of people living with HIV (PLHIV). Many of these deaths occur in developing countries. This study aimed at determining the incidence and predictors of tuberculosis among PLHIV.
A five year retrospective follow up study was conducted among adult PLHIV. The Cox proportional hazards model was used to identify predictors.
A total of 470 patients were followed and produced 1724.13 Person-Years (PY) of observation, and 136 new TB cases occurred during the follow up period. The overall incidence density of TB was 7.88 per 100 PY. It was high (95.9/100PY) in the first year of enrolment. The cumulative proportion of TB- free survivals was 79% and 67% at the end of the first and fifth years, respectively. Baseline WHO clinical stage III (AHR = 2.88, 95% CI = 1.53-5.43), WHO clinical stage IV (AHR = 3.82, 95% CI = 1.86-7.85), CD4 count <50 cell/ul (AHR = 2.13, 95% CI = 1.28-3.53) and ambulatory or bed ridden functional status (AHR = 1.64, 95%CI = 1.13-2.38) were predictors of time to TB occurrence.
TB incidence rate among PLHIV, especially in the first year of enrollment was high. Advanced WHO clinical stage, limited functional status, and low CD4 count (<50 cell cell/ul) were found to be the independent predictors of TB occurrence. Early care seeking and initiation of HAART to improve the CD4 count and functional status are important to reduce the risk of TB infection.